<SEC-DOCUMENT>0001193125-22-058209-index.html : 20220228
<SEC-HEADER>0001193125-22-058209.hdr.sgml : 20220228
<ACCEPTANCE-DATETIME>20220228170602
ACCESSION NUMBER:		0001193125-22-058209
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20220228
DATE AS OF CHANGE:		20220228
EFFECTIVENESS DATE:		20220228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apellis Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001492422
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				271537290
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-263100
		FILM NUMBER:		22691153

	BUSINESS ADDRESS:	
		STREET 1:		100 FIFTH AVENUE
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		617-977-5700

	MAIL ADDRESS:	
		STREET 1:		100 FIFTH AVENUE
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d267162ds8.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: d267162ds8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d267162dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: d267162dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>d267162dex232.htm
<DESCRIPTION>EX-23.2
<TEXT>
Document 3 - file: d267162dex232.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>d267162dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 4 - file: d267162dexfilingfees.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g267162dsp7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g267162dsp7.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g267162g0225205530210.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: g267162g0225205530210.jpg

</DOCUMENT>
</SEC-DOCUMENT>